Free shipping on all orders over $ 500

 About 1 result found for searched term "1262787-83-6" (0.122 seconds)

Cat.No.  Name Target
M24595 Patritumab EGFR/HER2
Human Anti-ERBB3 Recombinant Antibody
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab , potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.